A Study of Lasmiditan in Participants With Migraine

H8H-MC-LAHC -

The purpose of this study is to measure how much of the drug gets into the blood stream and how long it takes the body to get rid of it during an acute migraine attack and also during the time between acute migraine attacks.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Migraines
What the trial is testing?
Lasmiditan
Could I receive a Placebo?
No
Enrollment Goal
16
Trial Dates
Aug 16, 2017 - Jan 15, 2018
How long will I be in the trial?
Your participation could last approximately 6 weeks and may include overnight stays.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.